{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:01:12Z","timestamp":1790661672333,"version":"4.1.0"},"reference-count":98,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T00:00:00Z","timestamp":1434672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Due to high mutation rates, populations of RNA viruses exist as a collection of closely related mutants known as a quasispecies. A consequence of error-prone replication is the potential for rapid adaptation of RNA viruses when a selective pressure is applied, including host immune systems and antiviral drugs. RNA interference (RNAi) acts to inhibit protein synthesis by targeting specific mRNAs for degradation and this process has been developed to target RNA viruses, exhibiting their potential as a therapeutic against infections. However, viruses containing mutations conferring resistance to RNAi were isolated in nearly all cases, underlining the problems of rapid viral evolution. Thus, while promising, the use of RNAi in treating or preventing viral diseases remains fraught with the typical complications that result from high specificity of the target, as seen in other antiviral regimens.<\/jats:p>","DOI":"10.3390\/v7062768","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T10:23:33Z","timestamp":1434709413000},"page":"3226-3240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["RNA Viruses and RNAi: Quasispecies Implications for Viral Escape"],"prefix":"10.3390","volume":"7","author":[{"given":"John","family":"Presloid","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Immunology, College of Medicine, The University of Toledo, 3055 Arlington Avenue, Toledo, OH 43614, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Novella","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, College of Medicine, The University of Toledo, 3055 Arlington Avenue, Toledo, OH 43614, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1749-6632.1999.tb08870.x","article-title":"The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes","volume":"870","author":"Drake","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanjuan","year":"2010","journal-title":"J. Virol."},{"key":"ref_3","unstructured":"Eigen, M. (1992). Steps toward Life, Oxford University Press."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0966-842X(96)20011-3","article-title":"On the nature of virus quasispecies","volume":"4","author":"Eigen","year":"1996","journal-title":"Trends Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8240(88)80059-4","article-title":"Stationary mutant distributions and evolutionary optimization","volume":"50","author":"Schuster","year":"1988","journal-title":"Bull. Math. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0301-4622(82)87037-3","article-title":"Self-replication with errors. A model for polynucleotide replication","volume":"16","author":"Swetina","year":"1982","journal-title":"Biophys. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0092-8674(86)90600-8","article-title":"The mechanism of RNA recombination in poliovirus","volume":"47","author":"Kirkegaard","year":"1986","journal-title":"Cell"},{"key":"ref_8","first-page":"33","article-title":"Quasispecies in time-dependent environments","volume":"299","author":"Wilke","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1371\/journal.pcbi.0010061","article-title":"Quasispecies made simple","volume":"1","author":"Bull","year":"2005","journal-title":"PLoS Comput. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/jvi.69.1.23-31.1995","article-title":"Pol gene quasispecies of human immunodeficiency virus: Mutations associated with drug resistance in virus from patients undergoing no drug therapy","volume":"69","author":"Najera","year":"1995","journal-title":"J. Virol."},{"key":"ref_11","first-page":"1","article-title":"A new evolutionary law","volume":"1","year":"1973","journal-title":"Evol. Theory"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12980","DOI":"10.1073\/pnas.1117201109","article-title":"A quantitative quasispecies theory-based model of virus escape mutation under immune selection","volume":"109","author":"Woo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","first-page":"99","article-title":"Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants","volume":"48","author":"Domingo","year":"1997","journal-title":"Prog. Drug Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1003203","DOI":"10.1371\/journal.ppat.1003203","article-title":"Redefining the immune system as a social interface for cooperative processes","volume":"9","author":"Muraille","year":"2013","journal-title":"PLoS Pathog."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e01914","DOI":"10.7554\/eLife.01914","article-title":"Integrating influenza antigenic dynamics with molecular evolution","volume":"3","author":"Bedford","year":"2014","journal-title":"eLife"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrg2053","article-title":"The evolution of epidemic influenza","volume":"8","author":"Nelson","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Thyagarajan, B., and Bloom, J.D. (2014). The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin. eLife, 3.","DOI":"10.7554\/eLife.03300"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI78794","article-title":"Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance","volume":"125","author":"Bailey","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI79424","article-title":"The genetics of hepatitis C virus underlie its ability to escape humoral immunity","volume":"125","author":"Rolls","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1003878","DOI":"10.1371\/journal.pcbi.1003878","article-title":"The route of HIV escape from immune response targeting multiple sites is determined by the cost-benefit tradeoff of escape mutations","volume":"10","author":"Batorsky","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm992","article-title":"HIV evolution: CTL escape mutation and reversion after transmission","volume":"10","author":"Leslie","year":"2004","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: Clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/nm.3413","article-title":"Another HIV vaccine failure: Where to next?","volume":"19","author":"McMichael","year":"2013","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.vaccine.2013.05.018","article-title":"A brief history of the global effort to develop a preventive HIV vaccine","volume":"31","author":"Esparza","year":"2013","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11262-014-1089-1","article-title":"Genetic characterization of an H5N1 avian influenza virus from a vaccinated duck flock in Vietnam","volume":"49","author":"Bui","year":"2014","journal-title":"Virus Genes"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.3390\/v6103809","article-title":"Influenza vaccines: A moving interdisciplinary field","volume":"6","author":"Schotsaert","year":"2014","journal-title":"Viruses"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.antiviral.2006.05.016","article-title":"Antivirals for influenza: Historical perspectives and lessons learned","volume":"71","author":"Hayden","year":"2006","journal-title":"Antiviral Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza","volume":"360","author":"Moscona","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antiviral Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013\u20132014","volume":"117","author":"Takashita","year":"2015","journal-title":"Antiviral Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2014.12.003","article-title":"Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: Modeling studies of antibody and receptor binding","volume":"557","author":"Behera","year":"2015","journal-title":"Gene"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AEM.04034-14","article-title":"Oseltamivir-resistant influenza a (H1N1) virus strain with an H274Y mutation in neuraminidase persists without drug pressure in infected mallards","volume":"81","author":"Gillman","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_33","first-page":"119","article-title":"Update of the drug resistance mutations in HIV-1: 2007","volume":"15","author":"Johnson","year":"2007","journal-title":"Top. HIV Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JVI.01406-10","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization","volume":"85","author":"Shi","year":"2011","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2013.01.007","article-title":"Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments","volume":"98","year":"2013","journal-title":"Antiviral Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00109-001-0308-0","article-title":"Ribavirin\u2019s antiviral mechanism of action: Lethal mutagenesis?","volume":"80","author":"Crotty","year":"2002","journal-title":"J. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: Direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.1232294100","article-title":"A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity","volume":"100","author":"Pfeiffer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.11.007","article-title":"Ribavirin and lethal mutagenesis of poliovirus: Molecular mechanisms, resistance and biological implications","volume":"107","author":"Vignuzzi","year":"2005","journal-title":"Virus Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: A drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Debing, Y., Gisa, A., Dallmeier, K., Pischke, S., Bremer, B., Manns, M., Wedemeyer, H., Suneetha, P.V., and Neyts, J. (2014). A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology, 147.","DOI":"10.1053\/j.gastro.2014.08.040"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.01795-13","article-title":"Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon","volume":"58","author":"Debing","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1186\/1471-2180-1-34","article-title":"Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses","volume":"1","author":"Bitko","year":"2001","journal-title":"BMC Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt0502-500","article-title":"Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells","volume":"20","author":"Lee","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/nat.2012.0405","article-title":"Inhibition of Dengue virus 2 replication by artificial microRNAs targeting the conserved regions","volume":"23","author":"Xie","year":"2013","journal-title":"Nucleic Acid Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1073\/pnas.252783999","article-title":"Interference of hepatitis C virus RNA replication by short interfering RNAs","volume":"100","author":"Kapadia","year":"2003","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1128\/JVI.78.7.3436-3446.2004","article-title":"Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs","volume":"78","author":"Kronke","year":"2004","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1128\/JVI.01496-06","article-title":"Small interfering RNA targeted to hepatitis C virus 5\u2032 nontranslated region exerts potent antiviral effect","volume":"81","author":"Kanda","year":"2007","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1128\/JVI.78.13.6900-6907.2004","article-title":"RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice","volume":"78","author":"Chen","year":"2004","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1099\/vir.0.80133-0","article-title":"Inhibition of foot-and-mouth disease virus replication by small interfering RNA","volume":"85","author":"Kahana","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2011.10.023","article-title":"RNA interference inhibits replication of tick-borne encephalitis virus in vitro","volume":"93","author":"Achazi","year":"2012","journal-title":"Antiviral Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1073\/pnas.0437841100","article-title":"RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription","volume":"100","author":"Ge","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1099\/vir.0.79906-0","article-title":"Inhibition of influenza virus matrix (M1) protein expression and virus replication by U6 promoter-driven and lentivirus-mediated delivery of siRNA","volume":"85","author":"Hui","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"9225","DOI":"10.1128\/JVI.76.18.9225-9231.2002","article-title":"Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference","volume":"76","author":"Coburn","year":"2002","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature00896","article-title":"Modulation of HIV-1 replication by RNA interference","volume":"418","author":"Jacque","year":"2002","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1186\/1743-422X-9-118","article-title":"Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct","volume":"9","author":"Zhang","year":"2012","journal-title":"Virol. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1186\/1471-2180-14-78","article-title":"Gene silencing of beta-galactosamide alpha-2,6-sialyltransferase 1 inhibits human influenza virus infection of airway epithelial cells","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1128\/JVI.77.13.7174-7181.2003","article-title":"Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages","volume":"77","author":"Song","year":"2003","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.antiviral.2010.11.005","article-title":"Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors","volume":"89","author":"Eekels","year":"2011","journal-title":"Antiviral Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8682","DOI":"10.1073\/pnas.0402630101","article-title":"Protection against lethal influenza virus challenge by RNA interference in vivo","volume":"101","author":"Tompkins","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1086\/504267","article-title":"Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference","volume":"193","author":"Geisbert","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/v2071448","article-title":"siRNA for influenza therapy","volume":"2","author":"Barik","year":"2010","journal-title":"Viruses"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1369","article-title":"RNA interference against viruses: Strike and counterstrike","volume":"25","author":"Haasnoot","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2014.04.044","article-title":"Development of RNAi technology for targeted therapy\u2014A track of siRNA based agents to RNAi therapeutics","volume":"193","author":"Zhou","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tibtech.2010.07.009","article-title":"RNAi and small interfering RNAs in human disease therapeutic applications","volume":"28","author":"Lares","year":"2010","journal-title":"Trends Biotechnol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1371\/journal.pmed.0030096","article-title":"A single siRNA suppresses fatal encephalitis induced by two different flaviviruses","volume":"3","author":"Kumar","year":"2006","journal-title":"PLoS Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.coph.2010.04.011","article-title":"Antiretroviral drugs","volume":"10","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.gt.3302846","article-title":"Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA","volume":"14","author":"Chen","year":"2007","journal-title":"Gene Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.antiviral.2009.02.202","article-title":"Inhibition of porcine reproductive and respiratory syndrome virus replication by adenovirus-mediated RNA interference both in porcine alveolar macrophages and swine","volume":"82","author":"Li","year":"2009","journal-title":"Antiviral Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/JVI.79.2.1027-1035.2005","article-title":"Poliovirus escape from RNA interference: Short interfering RNA-target recognition and implications for therapeutic approaches","volume":"79","author":"Gitlin","year":"2005","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e26304","DOI":"10.1371\/journal.pone.0026304","article-title":"Broad-spectrum antiviral activity of RNA interference against four genotypes of Japanese encephalitis virus based on single microRNA polycistrons","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.1128\/JVI.79.11.7050-7058.2005","article-title":"Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5B coding region","volume":"79","author":"Wilson","year":"2005","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/molbev\/mss135","article-title":"Ultradeep sequencing analysis of population dynamics of virus escape mutants in RNAi-mediated resistant plants","volume":"29","author":"Martinez","year":"2012","journal-title":"Mol. Biol. Evol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/JVI.06210-11","article-title":"RNA interference against animal viruses: How morbilliviruses generate extended diversity to escape small interfering RNA control","volume":"86","author":"Holz","year":"2012","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1128\/JVI.77.21.11531-11535.2003","article-title":"Human immunodeficiency virus type 1 escape from RNA interference","volume":"77","author":"Boden","year":"2003","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","article-title":"Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition","volume":"78","author":"Das","year":"2004","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1128\/JVI.00078-06","article-title":"Effective suppression of human immunodeficiency virus type 1 through a combination of short- or long-hairpin RNAs targeting essential sequences for retroviral integration","volume":"80","author":"Nishitsuji","year":"2006","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/JVI.80.2.571-577.2006","article-title":"Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs","volume":"80","author":"Sabariegos","year":"2006","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2013.12.016","article-title":"Artificial microRNAs as antiviral strategy to FMDV: Structural implications of target selection","volume":"199","author":"Gismondi","year":"2014","journal-title":"J. Virol. Methods"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/mt.2012.3","article-title":"HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites","volume":"20","author":"Shah","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/mtna.2012.22","article-title":"HIV-1 escape from RNAi antivirals: Yet another houdini action?","volume":"1","author":"Berkhout","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/nar\/gki220","article-title":"HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome","volume":"33","author":"Westerhout","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3851\/IMP2064","article-title":"The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses","volume":"17","author":"DeVincenzo","year":"2012","journal-title":"Antivir. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2014.07.056","article-title":"Current issues of RNAi therapeutics delivery and development","volume":"195","author":"Haussecker","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","article-title":"Silencing of HIV-1 with RNA interference: A multiple shRNA approach","volume":"14","author":"Konstantinova","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/JVI.02035-07","article-title":"Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference","volume":"82","author":"Berkhout","year":"2008","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/mt.2009.176","article-title":"Combinatorial RNAi against HIV-1 using extended short hairpin RNAs","volume":"17","author":"Liu","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.antiviral.2009.09.009","article-title":"Novel approaches to inhibiting HIV-1 replication","volume":"85","author":"Adamson","year":"2010","journal-title":"Antiviral Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chom.2008.09.008","article-title":"HIV evades RNA interference directed at TAR by an indirect compensatory mechanism","volume":"4","author":"Leonard","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2013.02.011","article-title":"Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors","volume":"98","author":"Boutimah","year":"2013","journal-title":"Antiviral Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/emmm.200900023","article-title":"RNAi-based therapeutics-current status, challenges and prospects","volume":"1","author":"Tiemann","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1016\/j.febslet.2005.08.004","article-title":"The therapeutic potential of RNA interference","volume":"579","author":"Uprichard","year":"2005","journal-title":"FEBS Lett."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/6\/2768\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:48:08Z","timestamp":1760215688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/6\/2768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":98,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6]]}},"alternative-id":["v7062768"],"URL":"https:\/\/doi.org\/10.3390\/v7062768","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,19]]}}}